Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Direct Measurement of the Cosmic-Ray Proton Spectrum from 50 GeV to 10 TeV with the Calorimetric Electron Telescope on the International Space Station.

Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Berti E, Bigongiari G, Binns WR, Bonechi S, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Di Felice V, Ebisawa K, Fuke H, Guzik TG, Hams T, Hasebe N, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kohri K, Krawczynski HS, Krizmanic JF, Lomtadze T, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori K, Mori M, Mori N, Motz HM, Munakata K, Murakami H, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ozawa S, Pacini L, Palma F, Papini P, Penacchioni AV, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Suh JE, Sulaj A, Takahashi I, Takayanagi M, Takita M, Tamura T, Terasawa T, Tomida H, Torii S, Tsunesada Y, Uchihori Y, Ueno S, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K; CALET Collaboration.

Phys Rev Lett. 2019 May 10;122(18):181102. doi: 10.1103/PhysRevLett.122.181102.

PMID:
31144869
2.

[A case of leptomeningeal carcinomatosis involving loss of eyesight after total gastrectomy for gastric cancer].

Kurebayashi M, Hashimoto A, Ikenoyama Y, Tahara Y, Fuke H, Shimizu A, Kondo M, Nakano H, Kosaka T.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(8):755-759. doi: 10.11405/nisshoshi.115.755. Japanese.

PMID:
30101877
3.

Extended Measurement of the Cosmic-Ray Electron and Positron Spectrum from 11 GeV to 4.8 TeV with the Calorimetric Electron Telescope on the International Space Station.

Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Berti E, Bigongiari G, Binns WR, Bonechi S, Bongi M, Brogi P, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Di Felice V, Ebisawa K, Fuke H, Guzik TG, Hams T, Hareyama M, Hasebe N, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kohri K, Krawczynski HS, Krizmanic JF, Lomtadze T, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori K, Mori M, Mori N, Motz HM, Munakata K, Murakami H, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ozawa S, Pacini L, Palma F, Papini P, Penacchioni AV, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Suh JE, Sulaj A, Takahashi I, Takayanagi M, Takita M, Tamura T, Tateyama N, Terasawa T, Tomida H, Torii S, Tsunesada Y, Uchihori Y, Ueno S, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K; CALET Collaboration.

Phys Rev Lett. 2018 Jun 29;120(26):261102. doi: 10.1103/PhysRevLett.120.261102.

PMID:
30004739
4.

Energy Spectrum of Cosmic-Ray Electron and Positron from 10 GeV to 3 TeV Observed with the Calorimetric Electron Telescope on the International Space Station.

Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Bigongiari G, Binns WR, Bonechi S, Bongi M, Brogi P, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Di Felice V, Ebisawa K, Fuke H, Guzik TG, Hams T, Hareyama M, Hasebe N, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Javaid A, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Krawczynski HS, Krizmanic JF, Kuramata S, Lomtadze T, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Mizutani K, Moiseev AA, Mori K, Mori M, Mori N, Motz HM, Munakata K, Murakami H, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ozawa S, Pacini L, Palma F, Papini P, Penacchioni AV, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Takahashi I, Takayanagi M, Takita M, Tamura T, Tateyama N, Terasawa T, Tomida H, Torii S, Tsunesada Y, Uchihori Y, Ueno S, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Yuda T; CALET Collaboration.

Phys Rev Lett. 2017 Nov 3;119(18):181101. doi: 10.1103/PhysRevLett.119.181101. Epub 2017 Nov 1.

PMID:
29219544
5.

A case report of adenosquamous cell carcinoma of the duodenal papilla.

Segi Y, Hashimoto A, Yukimoto H, Yoshizawa N, Aoki M, Fuke H, Kawabata H, Shimizu A, Ichikawa K, Nakano H.

Nihon Shokakibyo Gakkai Zasshi. 2016;113(12):2067-2074. Review. Japanese.

PMID:
27916775
6.

Hepatology: Atypical images for multiple focal nodular hyperplasia.

Yoshizawa N, Fuke H, Hashimoto A, Shimizu A, Sugimoto K, Shiraki K, Isaji S.

J Gastroenterol Hepatol. 2015 Jun;30(6):969. doi: 10.1111/jgh.12870. No abstract available.

PMID:
25916482
7.

Education and imaging. Gastrointestinal: Spontaneous rupture of the pancreaticoduodenal artery from segmental arterial mediolysis.

Yamamoto T, Yoshizawa N, Fuke H, Hashimoto A, Sugimoto K, Shiraki K, Shimizu A.

J Gastroenterol Hepatol. 2014 Jun;29(6):1129. doi: 10.1111/jgh.12603. No abstract available.

PMID:
24832780
8.

Plexiform schwannoma of the rectum.

Kawaguchi S, Yamamoto R, Yamamura M, Oyamada J, Sato H, Fuke H, Yabana T.

Dig Endosc. 2014 Jan;26(1):113-6. doi: 10.1111/den.12022. Epub 2012 Dec 26. Review.

PMID:
23363231
9.

Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.

Beppu T, Sugimoto K, Shiraki K, Tameda M, Inagaki Y, Ogura S, Kasai C, Kusagawa S, Nojiri K, Yoneda M, Fuke H, Yamamoto N, Takei Y, Fujimori M, Hasegawa T, Yamanaka T, Uraki J, Kashima M, Takaki H, Nakatsuka A, Yamakado K, Takeda K.

Anticancer Res. 2012 Nov;32(11):4923-30.

PMID:
23155261
10.

Sarcomatous hepatocellular carcinoma with remittent fever.

Inagaki Y, Sugimoto K, Shiraki K, Yoshizawa N, Tameda M, Ogura S, Yoneda M, Takei Y, Fuke H, Hashimoto A, Yamamoto N, Shimizu A.

Intern Med. 2012;51(21):3025-9. Epub 2012 Nov 1.

11.

Search for antihelium with the BESS-Polar spectrometer.

Abe K, Fuke H, Haino S, Hams T, Hasegawa M, Horikoshi A, Itazaki A, Kim KC, Kumazawa T, Kusumoto A, Lee MH, Makida Y, Matsuda S, Matsukawa Y, Matsumoto K, Mitchell JW, Myers Z, Nishimura J, Nozaki M, Orito R, Ormes JF, Sakai K, Sasaki M, Seo ES, Shikaze Y, Shinoda R, Streitmatter RE, Suzuki J, Takasugi Y, Takeuchi K, Tanaka K, Thakur N, Yamagami T, Yamamoto A, Yoshida T, Yoshimura K.

Phys Rev Lett. 2012 Mar 30;108(13):131301. Epub 2012 Mar 29.

PMID:
22540691
12.

Measurement of the cosmic-ray antiproton spectrum at solar minimum with a long-duration balloon flight over antarctica.

Abe K, Fuke H, Haino S, Hams T, Hasegawa M, Horikoshi A, Kim KC, Kusumoto A, Lee MH, Makida Y, Matsuda S, Matsukawa Y, Mitchell JW, Nishimura J, Nozaki M, Orito R, Ormes JF, Sakai K, Sasaki M, Seo ES, Shinoda R, Streitmatter RE, Suzuki J, Tanaka K, Thakur N, Yamagami T, Yamamoto A, Yoshida T, Yoshimura K.

Phys Rev Lett. 2012 Feb 3;108(5):051102. Epub 2012 Jan 31.

PMID:
22400920
13.

[A case of jejunal malignant melanoma diagnosed by enteroscopy and pre-operative biopsy].

Kawaguchi S, Sugimoto S, Yamamoto R, Yamamura M, Oyamada J, Kuroda M, Kamei A, Sato H, Fuke H, Okuda Y, Yabana T.

Nihon Shokakibyo Gakkai Zasshi. 2011 Apr;108(4):633-9. Japanese.

PMID:
21467771
14.

[Prevention of collapse of community health care in the teaching hospital in Japan].

Fuke H.

Nihon Naika Gakkai Zasshi. 2009 Apr 10;98(4):921-5. Japanese. No abstract available.

PMID:
19469088
15.

Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.

Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K.

J Vasc Interv Radiol. 2009 Feb;20(2):217-24. doi: 10.1016/j.jvir.2008.10.019. Epub 2008 Dec 20.

PMID:
19097810
16.

Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.

Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Masuya M, Horie R, Uchida K, Takei Y.

Int J Oncol. 2008 Nov;33(5):929-36.

PMID:
18949355
17.

Protective role of interleukin-18 against Fas-mediated liver injury.

Yamamoto N, Murata K, Yoneda K, Fuke H, Yamaguchi Y, Ito K, Sugimoto K, Shiraki K, Yamanaka K, Mizutani H, Takei Y.

Int J Mol Med. 2008 Jul;22(1):43-8.

PMID:
18575774
18.

Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.

Tanaka J, Sugimoto K, Shiraki K, Beppu T, Yoneda K, Fuke H, Yamamoto N, Ito K, Takei Y.

Intern Med. 2008;47(8):747-9. Epub 2008 Apr 16.

19.

Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma.

Yoneda K, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Takei Y.

Intern Med. 2008;47(5):419-20. Epub 2008 Mar 3.

20.

Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

Yamakado K, Nakatsuka A, Takaki H, Yokoi H, Usui M, Sakurai H, Isaji S, Shiraki K, Fuke H, Uemoto S, Takeda K.

Radiology. 2008 Apr;247(1):260-6. doi: 10.1148/radiol.2471070818. Epub 2008 Feb 27.

PMID:
18305190
21.

Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.

Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A, Yamakado K, Takeda K, Takei Y.

Aliment Pharmacol Ther. 2008 Jun;27(12):1253-60. doi: 10.1111/j.1365-2036.2008.03627.x. Epub 2008 Jan 23.

22.

Role of poly (A) tail as an identity element for mRNA nuclear export.

Fuke H, Ohno M.

Nucleic Acids Res. 2008 Feb;36(3):1037-49. Epub 2007 Dec 20.

23.

Cervical mycotic aneurysm in a patient with alcoholic cirrhosis.

Yoneda K, Shiraki K, Tanaka J, Beppu T, Fuke H, Yamamoto N, Takei Y.

Intern Med. 2007;46(20):1693-5. Epub 2007 Oct 15.

24.

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.

Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):738-44. Epub 2007 Sep 21.

PMID:
17904524
25.

Tubulointerstitial nephritis associated with IgG4-related autoimmune disease.

Yoneda K, Murata K, Katayama K, Ishikawa E, Fuke H, Yamamoto N, Ito K, Shiraki K, Nomura S.

Am J Kidney Dis. 2007 Sep;50(3):455-62.

PMID:
17720525
26.

Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.

Takaki H, Yamakado K, Nakatsuka A, Fuke H, Murata K, Shiraki K, Takeda K.

J Vasc Interv Radiol. 2007 Jul;18(7):856-61.

PMID:
17609444
27.

Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection.

Inoue T, Fuke H, Yamamoto N, Ito K, Yutaka KY, Yamanaka, Shiraki K.

Hepatogastroenterology. 2007 Apr-May;54(75):889-91.

PMID:
17591085
28.

The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.

Miyashita K, Shiraki K, Fuke H, Inoue T, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

Int J Mol Med. 2006 Aug;18(2):249-56.

PMID:
16820931
29.

COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.

Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

Int J Mol Med. 2006 Jul;18(1):41-7.

PMID:
16786154
30.

Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL- and chemotherapeutic agent-induced cell death.

Yamaguchi Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Nakano T.

Biochim Biophys Acta. 2006 Aug;1763(8):844-53. Epub 2006 Apr 19.

31.

Gastric varix associated with autoimmune pancreatitis.

Fuke H, Shimizu A, Shiraki K.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):xxxii. Epub 2006 May 6. No abstract available.

PMID:
16682257
32.

Matrix metalloproteinase, hepatocyte growth factor, and tissue inhibitor of matrix metalloproteinase during human liver regeneration.

Fuke H, Saitou Y, Nakano T, Uemoto S, Shiraki K.

Liver Int. 2006 Apr;26(3):380-1. No abstract available.

PMID:
16584402
33.

Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.

Yamamoto K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Hamataki T, Shiraki K.

Oncol Rep. 2006 Apr;15(4):785-90.

PMID:
16525659
34.

Proteasome inhibition sensitizes hepatocellular carcinoma cells to TRAIL by suppressing caspase inhibitors and AKT pathway.

Inoue T, Shiraki K, Fuke H, Yamanaka Y, Miyashita K, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

Anticancer Drugs. 2006 Mar;17(3):261-8.

PMID:
16520654
35.

Primary biliary cirrhosis after aortoiliac reconstruction surgery using a Y-graft.

Inoue T, Shiraki K, Fuke H, Yamanaka Y, Miyashita K, Ito K, Suzuki M, Sugimoto K, Murata K, Nakano T.

World J Gastroenterol. 2005 Oct 21;11(39):6219-20.

36.

1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.

Yamamoto K, Shiraki K, Nakanishi S, Fuke H, Nakano T, Hashimoto A, Shimizu A, Hamataki T.

World J Gastroenterol. 2005 Sep 28;11(36):5607-13.

37.

Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.

Saitou Y, Shiraki K, Fuke H, Inoue T, Miyashita K, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

Hum Pathol. 2005 Oct;36(10):1066-73.

PMID:
16226105
38.
39.

Search for cosmic-ray antideuterons.

Fuke H, Maeno T, Abe K, Haino S, Makida Y, Matsuda S, Matsumoto H, Mitchell JW, Moiseev AA, Nishimura J, Nozaki M, Orito S, Ormes JF, Sasaki M, Seo ES, Shikaze Y, Streitmatter RE, Suzuki J, Tanaka K, Tanizaki K, Yamagami T, Yamamoto A, Yamamoto Y, Yamato K, Yoshida T, Yoshimura K.

Phys Rev Lett. 2005 Aug 19;95(8):081101. Epub 2005 Aug 16.

PMID:
16196846
40.

Different effects of bile acids, ursodeoxycholic acid and deoxycholic acid, on cell growth and cell death in human colonic adenocarcinoma cells.

Shiraki K, Ito T, Sugimoto K, Fuke H, Inoue T, Miyashita K, Yamanaka T, Suzuki M, Nabeshima K, Nakano T, Takase K.

Int J Mol Med. 2005 Oct;16(4):729-33.

PMID:
16142412
41.

The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.

Yamamoto K, Shiraki K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Nakano T.

Int J Oncol. 2005 Oct;27(4):989-95.

PMID:
16142315
42.

Macrocytic anemia during low-dose cisplatin and 5-Fluorouracil through implanted infusion port for unresectable hepatobilliary malignancies.

Yamamoto N, Murata K, Fuke H, Inoue T, Yamanaka Y, Saitou Y, Ito K, Sugimoto K, Koyama M, Shiraki K, Nakano T.

Anticancer Res. 2005 Mar-Apr;25(2B):1243-6.

43.

Ileocolonic lymphomas: a series of 16 cases.

Saito T, Toyoda H, Yamaguchi M, Nakamura T, Nakamura S, Mukai K, Fuke H, Wakita Y, Iwata M, Adachi Y, Shiku H.

Endoscopy. 2005 May;37(5):466-9.

PMID:
15844027
44.

Cardiac metastases of gallbladder carcinoma.

Inoue T, Shiraki K, Fuke H, Yamanaka Y, Miyashita K, Ito K, Suzuki M, Sugimoto K, Murata K, Nakano T.

World J Gastroenterol. 2005 Apr 7;11(13):2048-9.

45.

Usefulness of digital subtraction imaging with Levovist in the diagnosis of hepatocellular carcinomas.

Yamamoto K, Shiraki K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Nakano T.

Oncol Rep. 2005 Jan;13(1):95-9.

PMID:
15583808
46.

Computed tomographic image of an inflammatory fibroid polyp of the stomach.

Fuke H, Hashimoto A, Shimizu A, Yoshimura H, Nakano T, Shiraki K.

Clin Imaging. 2003 Nov-Dec;27(6):400-2.

PMID:
14585568
47.

Treatment of traumatic pancreatic duct disruption with an endoscopic stent.

Hashimoto A, Fuke H, Shimizu A, Nakano T, Shiraki K.

Pancreas. 2003 Apr;26(3):308-10. No abstract available.

PMID:
12657960
48.

The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.

Yamamoto K, Shiraki K, Nakanishi S, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Fuke H, Hashimoto A, Shimizu A, Okuda Y, Nakano T.

Int J Oncol. 2003 Feb;22(2):353-8.

PMID:
12527934
49.

Hepatic portal venous gas caused by non-obstructive mesenteric ischemia.

Hashimoto A, Fuke H, Shimizu A, Shiraki K.

J Hepatol. 2002 Dec;37(6):870. No abstract available.

PMID:
12445432
50.

Measurements of cosmic-ray low-energy antiproton and proton spectra in a transient period of solar field reversal.

Asaoka Y, Shikaze Y, Abe K, Anraku K, Fujikawa M, Fuke H, Haino S, Imori M, Izumi K, Maeno T, Makida Y, Matsuda S, Matsui N, Matsukawa T, Matsumoto H, Matsunaga H, Mitchell J, Mitsui T, Moiseev A, Motoki M, Nishimura J, Nozaki M, Orito S, Ormes JF, Saeki T, Sanuki T, Sasaki M, Seo ES, Sonoda T, Streitmatter R, Suzuki J, Tanaka K, Tanizaki K, Ueda I, Wang JZ, Yajima Y, Yamagami Y, Yamamoto A, Yamamoto Y, Yamato K, Yoshida T, Yoshimura K.

Phys Rev Lett. 2002 Feb 4;88(5):051101. Epub 2002 Jan 16.

PMID:
11863712

Supplemental Content

Support Center